Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation

被引:195
作者
Grimley, PM [1 ]
Dong, F
Rui, H
机构
[1] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD 20854 USA
[2] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA
关键词
Stat5a; Stat5b; janus kinases (Jak); transcription factors; signal transduction;
D O I
10.1016/S1359-6101(99)00011-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stat5a and Stat5b are discretely encoded transcription factors that mediate signals for a broad spectrum of cytokines. Their activation is often an integral component of redundant cytokine signal cascades involving complex cross-talk and pleiotropic gene regulation by Stat5 has been implicated in cellular functions of proliferation, differentiation and apoptosis with relevance to processes of hematopoiesis and immunoregulation, reproduction, and lipid metabolism. Although Stat5a and Stat5b show peptide sequence similarities of >90%, targeted gene disruptions in mice yield distinctive phenotypes. Prolactin-directed mammary gland maturation fails without functional Stat5a, while disruption of Stat5b in males mitigates growth hormone effects on hepatic function and body mass. The molecular basis for this biologic dichotomy is probably multifaceted. Limited structural dissimilarities between the Stat5a and Stat5b transactivation domains, or subtle differences in the DNA-binding affinities of Stat5 dimer pairs undoubtedly influence gene regulation, but cell-dependent asymmetries in availability of phosphorylated Stat5 can be an underlying factor. Differences in serine phosphorylation(s) of Stat5a and Stat5b, or Stat5 associations with adaptor proteins or co-transcription factors are other potential sources of functional disparity and the signal amplitude, frequency or duration also can be significant. In addition to Stat5 signal attenuation by phosphatase actions or classical feedback inhibition, truncated forms of Stat5 lacking in transactivation capacity may compete upstream for activation and diminish access of full length molecules to DNA binding sites. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:131 / 157
页数:27
相关论文
共 279 条
[81]   Prolactin signal transduction to milk protein genes: Carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation [J].
Goupille, O ;
Daniel, N ;
Bignon, C ;
Jolivet, G ;
Djiane, J .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 127 (02) :155-169
[82]   Prolonged STAT1 activation related to the growth arrest of malignant lymphoma cells by interferon-α [J].
Grimley, PM ;
Fang, H ;
Rui, H ;
Petricoin, EF ;
Ray, S ;
Dong, F ;
Fields, KH ;
Hu, RQ ;
Zoon, KC ;
Audet, S ;
Beeler, J .
BLOOD, 1998, 91 (08) :3017-3027
[83]  
Guo DQ, 1998, J IMMUNOL, V160, P2742
[84]  
Hackett RH, 1997, J BIOL CHEM, V272, P11128
[85]   Participation of JAK and STAT proteins in growth hormone-induced signaling [J].
Han, YL ;
Leaman, DW ;
Watling, D ;
Rogers, NC ;
Groner, B ;
Kerr, IM ;
Wood, WI ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5947-5952
[86]   JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription [J].
Han, YL ;
Watling, D ;
Rogers, NC ;
Stark, GR .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (08) :1180-1188
[87]   CONTRIBUTION OF STAT SH2 GROUPS TO SPECIFIC INTERFERON SIGNALING BY THE JAK-STAT PATHWAY [J].
HEIM, MH ;
KERR, IM ;
STARK, GR ;
DARNELL, JE .
SCIENCE, 1995, 267 (5202) :1347-1349
[88]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314
[89]   Prolactin signaling in mammary gland development [J].
Hennighausen, L ;
Robinson, GW ;
Wagner, KU ;
Liu, XW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :7567-7569
[90]   A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B [J].
Herrington, J ;
Rui, LY ;
Luo, GY ;
Yu-Lee, LY ;
Carter-Su, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :5138-5145